Real-time PCR analysis revealed upregulated ADAM10 (Figure 11a–c) and ADAM17 (Figure 11d–f) expression with simultaneously reduced miR-145 expression levels (Figure 11a,d) for all 15 RB patients. This evidence concerns the gene ADAM10 and retinoblastoma.